| scholarly article | Q13442814 |
| P50 | author | Paolo Fusar-Poli | Q21094931 |
| James Stone | Q43280374 | ||
| P2093 | author name string | Alice Egerton | |
| P433 | issue | 4 | |
| P921 | main subject | psychosis | Q170082 |
| P304 | page(s) | 466-478 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | Current Pharmaceutical Design | Q5195068 |
| P1476 | title | Glutamate and psychosis risk | |
| P478 | volume | 18 |
| Q38759421 | Altering the course of schizophrenia: progress and perspectives |
| Q36234271 | Anterior cingulate glutamate levels related to clinical status following treatment in first-episode schizophrenia |
| Q36043389 | Apoptotic markers in cultured fibroblasts correlate with brain metabolites and regional brain volume in antipsychotic-naive first-episode schizophrenia and healthy controls. |
| Q38762872 | Brain-imaging studies of treatment-resistant schizophrenia: a systematic review |
| Q47895125 | Developmental timing and critical windows for the treatment of psychiatric disorders. |
| Q96817727 | Galantamine-Memantine Combination as an Antioxidant Treatment for Schizophrenia |
| Q55312811 | Glutamate Concentration in the Superior Temporal Sulcus Relates to Neuroticism in Schizophrenia. |
| Q51736795 | Group II metabotropic glutamate receptor agonist prodrugs LY2979165 and LY2140023 attenuate the functional imaging response to ketamine in healthy subjects. |
| Q33662831 | In SilicoModel-driven Assessment of the Effects of Brain-derived Neurotrophic Factor Deficiency on Glutamate and Gamma-Aminobutyric Acid: Implications for Understanding Schizophrenia Pathophysiology. |
| Q28083121 | In vivo assessment of neurotransmitters and modulators with magnetic resonance spectroscopy: application to schizophrenia |
| Q34270086 | Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosis |
| Q26830600 | Stress and neurodevelopmental processes in the emergence of psychosis |
| Q38232366 | The neurobiology and treatment of first-episode schizophrenia |
| Q34073533 | The prodrome and clinical risk for psychotic disorders |
| Q38249908 | What causes aberrant salience in schizophrenia? A role for impaired short-term habituation and the GRIA1 (GluA1) AMPA receptor subunit. |
Search more.